abstract |
The present invention relates to a compound represented by the formula (I): [wherein R1 to R3, X and Y are as defined in the present specification and claims] and a pharmaceutically acceptable salt thereof. Relates to the salt obtained. The compounds of the formula (I) can be used as medicaments for the treatment and / or prevention in mammals of inflammatory diseases or disorders, in particular as transient receptor potential (TRP) channel antagonists. . |